Dr. Shude Cui 崔树德
Chief Physician
Department of Breast Surgery, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Early diagnosis and multidisciplinary treatment of malignant breast tumors. Focuses on standardized and individualized breast cancer therapy, including breast-conserving surgery, reconstruction, sentinel lymph node biopsy, and minimally invasive techniques.
Dr. Cui is Chief Physician, Professor of Oncology, and Director of the Breast Department at Henan Cancer Hospital. Dr. Cui serves as Director of the Henan Breast Diagnosis and Treatment Center and Institute of Breast Tumors. A recipient of the State Council special allowance, Dr. Cui has published over 30 papers and authored six books.
Professional roles
- Standing Committee Member, Breast Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Breast Disease Training Expert Committee, Chinese Medical Doctor Association
- Chair, Breast Cancer Professional Committee, Henan Anti-Cancer Association
- Editorial Board Member, Chinese Edition of Annals of Oncology (Breast Cancer Special Issue)
Name order: in Chinese the family name comes first (Cui Shude). Papers usually list the name as Shude Cui or Cui S.
Selected publications
40 papers on PubMed matched by name and affiliation; 1 as first or senior author since 2016. Most recent first- or senior-author papers:
- BioDrugs, 2016 (senior author): A Retrospective Study on the Efficacy of Trastuzumab in HER2-Positive and Tamoxifen-Refractory Breast Cancer with Brain Metastasis. PubMed 26792291
- Pak J Pharm Sci, 2015 (senior author): Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer. PubMed 26051718
- Chin J Cancer Res, 2014 (senior author): Efficacy of capecitabine-based combination therapy and single-agent capecitabine maintenance therapy in patients with metastatic breast cancer. PubMed 25561767
- Oncol Lett, 2014 (senior author): A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy. PubMed 25289086
- Chin J Cancer Res, 2014 (senior author): Maintenance treatment of trastuzumab for patients with advanced breast cancer to achieve long term survival: two case reports and literature review. PubMed 25232224
- Chin Med J (Engl), 2013 (senior author): High risk factors of brain metastases in 295 patients with advanced breast cancer. PubMed 23557557
- Zhonghua Yi Xue Za Zhi, 2011 (senior author): [Predicative value of 99mTc-MIBI scintimammography in neoadjuvant chemotherapeutic effect of patients with operable breast cancer]. PubMed 21418909
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion